Bayer and OrigiMed reached a partnership on CDx-IVD development

2020-07-24

OrigiMed

• Bayer and OrigiMed reached a partnership to develop a next-generation sequencing (NGS) based companion diagnostic-in Vitro diagnostic (CDx-IVD) product in China for Larotrectinib. NTRK gene fusion detection

• The collaboration will begin with the development of a CDx-IVD for larotrectinib for the Chinese market. Larotrectinib is the world’s first TRK inhibitor to be approved in patients with TRK gene fusion cancer in all solid tumors in the United States (2018) and Europe (2019)

• The collaboration aims to develop a kit for China that helps to identify all TRK fusion cancer patients who may benefit from therapy.

Beijing, Shanghai, April 30th, 2020 - Bayer and OrigiMed (Shanghai) Co., Ltd. (referred to as "OrigiMed") today announced a strategic collaboration for the development and commercialization of NGS-based companion diagnostics – in vitro diagnostic (CDx-IVD) in China for detection of NTRK gene fusions. This collaboration will focus on developing a CDx-IVD for larotrectinib (Vitrakvi®) for the Chinese market, the first TRK inhibitor approved in the US (2018) and Europe (2019) for adult and pediatrics with TRK fusion cancer and is currently developed globally, including in China.

"Approved in various markets already including the US and EU, larotrectinib is a first-of-its-kind treatment exclusively designed for adults and children with TRK fusion cancer. It is also the first compound that received it's initial approved based on the molecular alteration (NTRK gene fusion) driving their cancer irrespective of the tumor site of origin," said Dr. Emmanuelle di Tomaso, Head of Oncology Precision Medicine, Bayer's Oncology Strategic Business Unit, "Cancer care is currently undergoing a paradigm shift, and as this new era of precision oncology treatment unfolds, we are continuing our effort of delivering innovative medicines such as larotrectinib, which can provide value to patients and their treating physicians around the world."

"As one of the first NGS companies to introduce NTRK gene fusion detection in China, we are looking forward to working with Bayer to develop larotrectinib CDx-IVD, jointly support clinical trials of larotrectinib in mainland China and provide therapeutic benefits for more patients." The genomic testing and analysis of cancer patients to determine whether they are suitable for the treatment of larotrectinib is also a very urgent clinical need," said Dr. Wang Kai, CEO of OrigiMed.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the significant challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com .

About OrigiMed

OrigiMed is a medical science and technology transforming company and a partner of biopharmaceutical companies, who focuses on developing new technologies and clinical applications to help all types of cancer patients get access to precise treatment and help accelerate biomarker-driven drug development. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation to help match patients to approved targeted therapies, immunotherapies, and clinical trials-giving physicians and patients powerful actionable insights for navigating cancer care, ultimately aiming to fortify the evolution of cancer precision medicine. More information, please visit www.origimed.com

Company：OrigiMed

Website: www.origimed.com

Contact: Amy Huang

Telephone: 86-13052471970

Email: huangj@origimed.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Sunflower: The Highly Anticipated Digital Industry Incubator of 2024

In early April 2024, amidst the bustling Web3 Carnival at the picturesque Victoria Harbour in Hong Kong, the Deputy Financial Secretary of the Hong Kong Special Administrative Region, Mr. Wayne Wong, emphasized the importance of striking a balance between development promotion and appropriate regulation, particularly in the realm of virtual assets. He emphasized that a comprehensive and clear regulatory system is key to fostering the sustainable development of virtual assets.
Sunflower，Borderless Green Philanthropic Digital Industry Incubator

The greatness of a revolutionary technology lies not merely in its impact within the technical realm but in its transcendent disruption of production relations and people's daily lives. The internet epitomizes this, and so does blockchain.
NYO3 Follows the Sustainable Fishing Principle and Work with AWR to Protect the Ecological Vitality of Antarctic Oceans
The requirement for shampoo has continuously increased—how does Mosaly distinguish itself amidst the plethora of hair care brands?

Hair care formulations stand as a predominant segment within the sphere of daily chemical products ubiquitously utilized by patrons. Amid the relentless quest for an elevated standard of living, such hair care essentials have ascended to a pinnacle of paramount interest among the populace of China. Presently, the consumer base exhibits a penchant for a diverse and specialized array of shampoo products, manifesting varied predilections towards attributes including restorative, smoothing, dandruff eradication, colouration, perming, and anti-hair fall properties, whilst bestowing increased scruti
Mosaly: A Novel Option for Sustainable Scalp Health

In an era characterized by rapid lifestyles, there is a growing emphasis on health and ecological preservation. Within this scenario, the Mosaly brand has surfaced, presenting an innovative solution for scalp wellness with its anti-dandruff offerings, which are primarily formulated with Chinese tea polyphenols.
Mosaly: Narrating the stories of oriental plants, creating a philosophy of natural cleansing and care.

Amid a burgeoning revival of Chinese cultural heritage, an innovative cohort of consumer brands that encapsulate Eastern aesthetics and traditional ethos have risen to prominence. Within this milieu, the "China Tea Craze" epitomizes this cultural resurgence. Within such a framework, Mosaly, as a trailblazing personal care brand that integrates the symbolism of Oriental tea culture into its offerings, has undoubtedly injected a refreshing vitality into the sector.
Mosaly: Dominating Douyin's Monthly Hair Care Charts, What Drives the Rise of China's New Hair Care Force?

As the advent of the Double 11 shopping extravaganza draws near, Douyin's monthly hair care leaderboards have surprisingly catalyzed a resurgence of Chinese labels, with Mosaly hair care formulations rising prominently as the foremost vanguard. Across an array of indexes, it claims a preeminent station through both its unparalleled product efficacy and its veneration among luminaries, heralding not merely the ascendancy of Chinese craftsmanship but also mirroring a paradigm shift within contemporary consumer ethos.
The 10 Most Trusted Immigration Agents and Agencies of 2024

Moving to a new country is never easy.The best immigration agents and agencies strive to provide their clients with the best possible outcome, regardless of their circumstances. Here you will find some dedicated professionals! Below are the top ten immigration consulting firms in the world chosen by hundreds of thousands of expats.
Sunflower, the Tears of the Era or the Layout of Leading Institutions?

In 2024, the U.S. Securities and Exchange Commission approved the listing of the first batch of 11 Bitcoin spot exchange-traded funds (ETFs), with net inflows of approximately $10 billion within two months. Spot Bitcoin ETFs attracted most of the global attention and investment, serving as a rapid development and maturity example in the field and providing a template for achieving more results with other cryptocurrencies. Currently, the total market value of cryptocurrencies is approximately $26 trillion.
Global Times: Social media spat over 'Oppenheimer' sparks backlash as US netizens learn of horrific deeds by Japanese aggressors

With the release of the movie Oppenheimer in Japan igniting heated discussion, terms including "Unit 731" and "Nanjing [Massacre]" have risen to the top of the search bar on American social media platforms in recent days, with many appalled by Japanese atrocities in China during World War II.